Steven C. Reitz

Statistics

Publications

Citations

344

H-Index

Active since

2006

Affiliations

Pfizer (United States)(Current)

Steven C. Reitz is an author at Pfizer (United States) specializing in cholinergic pharmacology, agonists of cholinergic receptors, and neuropharmacology.

Publications per year

2006–2008

Publications

Discovery ofN-[(3R)-1-Azabicyclo[2.2.2]oct-3-yl]furo[2,3-c]pyridine-5-carboxamide, an Agonist of the α7 Nicotinic Acetylcholine Receptor, for the Potential Treatment of Cognitive Deficits in Schizophrenia: Synthesis and Structure−Activity Relationship

Donn G. Wishka, Daniel P. Walker, Karen M. Yates et al. · Journal of Medicinal Chemistry · 2006 · 190 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

Design, synthesis, structure–activity relationship, and in vivo activity of azabicyclic aryl amides as α7 nicotinic acetylcholine receptor agonists

Daniel P. Walker, Donn G. Wishka, David W. Piotrowski et al. · Bioorganic & Medicinal Chemistry · 2006 · 94 citations

Medicine, Medicinal Chemistry, Pharmacology +17

Discovery of N-[(3R,5R)-1-azabicyclo[3.2.1]oct-3-yl]furo[2,3-c]pyridine-5-carboxamide as an agonist of the α7 nicotinic acetylcholine receptor: In vitro and in vivo activity

Brad A. Acker, E. Jon Jacobsen, Bruce N. Rogers et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 60 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +14

1–3 of 3